Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACH7 TECHNOLOGIES LIMITED Capital/Financing Update 2015

Oct 25, 2015

65285_rns_2015-10-25_8ed0776b-5a30-4700-907f-517243727fa5.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [333 x 175] intentionally omitted <==

MARKET RELEASE

26 October 2015

3D Medical Limited

TRADING HALT

The securities of 3D Medical Limited (the “Company”) will be placed in Trading Halt Session State at the request of the Company, pending the release of an announcement by the Company. Unless ASX decides otherwise, the securities will remain in Trading Halt Session State until the earlier of the commencement of normal trading on Wednesday, 28 October 2015 or when the announcement is released to the market.

Security Code: 3DM

Kate Kidson

PRINCIPAL ADVISER, LISTINGS COMPLIANCE (MELBOURNE)

www.asx.com.au Sender Phone Customer service 13 12 79 Sender Email

20 Bridge Street Sydney NSW 2000

ASX Compliance Pty Limited ABN 26 087 780 489

==> picture [595 x 97] intentionally omitted <==

26 October 2015

Kate Kidson Principal Adviser, Listings Compliance (Melbourne) ASX Compliance Pty Limited Level 4 North Tower, 525 Collins Street Melbourne VIC 3000

By email only: [email protected]

Dear Kate

REQUEST FOR TRADING HALT 3D MEDICAL LIMITED

3D Medical Limited (ASX: 3DM ) (the Company ) requests an immediate halt to the trading of the Company’s ordinary shares quoted on the Australian Securities Exchange ( ASX ), effective prior to commencement of normal trading today, Monday 26 October 2015, in accordance with ASX Listing Rule 17.1.

The trading halt is requested pending an announcement to be made by the Company to the market regarding the outcome of the Company’s institutional capital raising placement, details of which are provided in the Company’s announcement dated 26 October 2015 ( Offer ).

In accordance with Listing Rule 17.1, the Company provides the following information in relation to the request:

  1. The trading halt is necessary to assist the Company in managing its continuous disclosure obligations as the Company expects to make a material announcement to the market in relation to the outcome of the Offer.

  2. The Company requests that the trading halt remains in place until the earlier of commencement of normal trading on Wednesday 28 October 2015, or when the announcement regarding the outcome of the Offer is released to the market.

  3. The Company expects to make the announcement to the market before the commencement of normal trading on Wednesday 28 October 2015.

  4. The Company is not aware of any reason why the trading halt should not be granted or of any further information necessary to inform the market about the trading halt.

Please contact me if you require any further information concerning this matter.

Yours sincerely

Alyn Tai Company Secretary

3D Medical Limited ACN 007 817 192 Unit 4, 435 Williamstown Road, Port Melbourne, Victoria 3207 W:www.3Dmedical.com.au I E:[email protected] I T:+613 9646 2222 I F:+613 9645 4707